Apotea (APOTEA) - Total Assets
Based on the latest financial reports, Apotea (APOTEA) holds total assets worth Skr2.23 Billion SEK (≈ $239.53 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See current stock price of Apotea for real-time trading data and today's change.
Apotea - Total Assets Trend (2021–2025)
This chart illustrates how Apotea's total assets have evolved over time, based on quarterly financial data. Also see Apotea operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Apotea - Asset Composition Analysis
Current Asset Composition (December 2025)
Apotea's total assets of Skr2.23 Billion consist of 56.5% current assets and 43.5% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 0.2% |
| Accounts Receivable | Skr45.58 Million | 2.3% |
| Inventory | Skr70.54 Million | 3.6% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr1.53 Million | 0.1% |
| Goodwill | Skr3.30 Million | 0.2% |
Asset Composition Trend (2021–2025)
This chart illustrates how Apotea's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore APOTEA net working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Apotea's current assets represent 56.5% of total assets in 2025, a decrease from 69.4% in 2021.
- Cash Position: Cash and equivalents constituted 0.2% of total assets in 2025, down from 7.9% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is inventory at 3.6% of total assets.
Apotea Competitors by Total Assets
Key competitors of Apotea based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Raia Drogasil S.A
SA:RADL3
|
Brazil | R$25.13 Billion |
|
Dashenlin Pharm Grp Co Ltd
SHG:603233
|
China | CN¥26.83 Billion |
|
Redcare Pharmacy NV
F:RDC
|
Germany | €1.21 Billion |
|
Empreendimentos Pague Menos S.A
SA:PGMN3
|
Brazil | R$9.81 Billion |
|
d1000 Varejo Farma Participações S.A
SA:DMVF3
|
Brazil | R$1.95 Billion |
|
High Tide Inc
V:HITI
|
Canada | CA$347.87 Million |
|
Yifeng Pharmacy
SHG:603939
|
China | CN¥26.07 Billion |
|
Laobaixing Pharmacy
SHG:603883
|
China | CN¥19.91 Billion |
Apotea - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.40 | 1.18 | 1.03 |
| Quick Ratio | 0.58 | 0.55 | 0.49 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr417.10 Million | Skr171.00 Million | Skr24.70 Million |
Apotea - Advanced Valuation Insights
This section examines the relationship between Apotea's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 7.99 |
| Latest Market Cap to Assets Ratio | 0.42 |
| Asset Growth Rate (YoY) | 1251.9% |
| Total Assets | Skr1.98 Billion |
| Market Capitalization | $830.46 Million USD |
Valuation Analysis
Below Book Valuation: The market values Apotea's assets below their book value (0.42x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Apotea's assets grew by 1251.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Apotea (2021–2025)
The table below shows the annual total assets of Apotea from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr1.98 Billion ≈ $213.13 Million |
+1251.94% |
| 2024-12-31 | Skr146.49 Million ≈ $15.76 Million |
+10.83% |
| 2023-12-31 | Skr132.18 Million ≈ $14.22 Million |
-89.45% |
| 2022-12-31 | Skr1.25 Billion ≈ $134.79 Million |
+22.23% |
| 2021-12-31 | Skr1.02 Billion ≈ $110.28 Million |
-- |
About Apotea
Apotea AB (publ) operates an online pharmacy in Sweden. The company offers products in the areas of allergy, face, baby, child and parent, bite and sting, preparedness, animal, fever and aches, cold, home and household, aid, hair removal and shaving, hair care, hands and feet, intimate, and dietary supplements. It also provides products in the categories of body care, stomach and intestine, food … Read more